Patented Technology Creating a Seal Over the Arterial Access Site

Slides:



Advertisements
Similar presentations
Absorbable Hemostatic Gelatin Sponge
Advertisements

Making Procedures Safe(r) Central Line Insertion Paul Currier, MD, MPH MGH Pulmonary & Critical Care Unit Associate Program Director for Procedures and.
Infection Control: IV Drug Administration
CARE OF THE CARDIAC CATH PATIENT Meg Morris, RN, CCRN, Nurse Clinician II Zir Cardiac Cath Lab January 20, 2011.
MO CKD This material was prepared by Primaris, the Medicare Quality Improvement Organization for Missouri, under contract with the Centers for Medicare.
Welcome to the BioSeal CVC Powder Application Computer-Based Learning Module (CBL) Who should take this CBL? Any clinician that will insert, maintain or.
GBMC Corporate Competency Health, healing and hope.
RadiStop™ Compression Assist Device
TCCC Guidelines: Tourniquets & Hemostatic Agents (Paraphrased)
NUR 141: SKILL 28-4: CHANGING INFUSION TUBING
Bringing Solutions to Vascular Medicine ML2303 Rev A 10/10.
Medication Assistant Training Module 5 Eyes Ears Nose.
On the CUSP: STOP BSI Central Line Dressing Change
ECLIPSE Trial: Ensure’s Vascular Closure Device Speeds Hemostasis S. Chiu Wong MD Director, Cardiac Catheterization Laboratories New York Presbyterian.
Strategies for Improving Adequacy Decreasing the Risk of Premature Death Educate Your Dialysis Team Review Proper Procedure for Drawing Lab Samples - Lab.
For Urgent and Unexpected Cases
Vascular Closure Devices. What is a Closure Device Vascular closure devices seal the puncture site in an artery (the arteriotomy) through mechanical means.
Urinary – Nephrostomy Catheter Care
IRTB - Arterial Access and Angioplasty Dr Hilary White Nottingham.
HemaBlock Hemostatic Powder Application R.A.P.I.D. 5-Step R.A.P.I.D. Application Procedure For successful results the “HemaBlock 5-Step R.A.P.I.D. Application.
1 © 2013 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part, except for use as permitted in a license.
1 Today’s Technology to Keep Access Sites Dry and Intact.
Central Venous Catheterization UNC Emergency Medicine Medical Student Lecture Series.
Central Line Removal Competency Assessment for Registered Professional Nurses in the Critical Care Areas References: AACN Procedure Manual for Critical.
HEMORRHAGE CONTROL RIFLES LIFESAVERS. Core SkillsControl Bleeding2 Introduction Review types of injuries Review types of injuries Review Tactical Combat.
Suture Materials ABSORBABLE: lose their tensile strength within 60 days. NON- ABSORBABLE:
BioSeal CVC Powder Application
7- Intravenous (I.V) Infusion
Welcome to the BioSeal CVC Powder Application Computer-Based Learning Module (CBL) Who should take this CBL? Any clinician that will insert, maintain or.
Laboratory Training for Field Epidemiologists Best infection control measures for sampling venous and capillary blood WHO intermediate recommendations.
Starting a Peripheral IV Principles of IV Therapy BSN336 Lab.
1 TLB PowerPoint presented By Takaya L. Brown, BSN, BSN, CMSRN.
PRPEARED BY : SALWA MAGHRABI CLINICAL INSTRUCTOR
OBJECTIVES  We will apply health knowledge and skills to the development and analysis of personal goals to achieve and maintain long-term health and wellness.
INTRODUCTION RESULTS METHODS METHODS RESULTS In Japan, many patients receive hemodialysis treatment that lasts for decades. These patients have thin and.
Prepared by: Salwa Maghrabi Teacher Assistant Nursing Department Arterial Blood Gases.
Erythrocyte Count Normal ranges:
Dressing and Bandaging
Gail Vanairsdale Global Clinical Education Manager Enlite Sensor Insertion.
Administration of Vaccine via Intramuscular Route
Session V A, Slide #1 Contraceptive Implants Session V A: Two-Rod Implant Insertion.
The Science of a “Seal” for PICC Line Management: An Alternative Hemostatic Agent That Keeps Sites Dry and Intact Lauren Blough, RN, BS, CRNI; Kathy.
Sterile Techniques. Surgical Asepsis A. Involves keeping the clinical setting and objects as free from microorganisms as possible. B. Used in operating.
Implanted Ports: Procedure for Access and Care
Administration of Vaccine via Subcutaneous Route Hand hygiene is the first step in medication administration is hand hygiene. Use either an alcohol-based.
Done by : Salwa Maghrabi Teacher assistant Nursing department
PCI What You Need to Know!. What and Where Radial- advantages  Immediate ambulation  Easily compressible vessel  Less risk of nerve injury  Dual blood.
CLS 424 Phlebotomy Student Lab Rotation
Blood collection.  Venipuncture is the collection of blood from a vein. As a general rule, arm veins are the best source from which to obtain blood.
Smallpox Vaccine Administration  Learning Objectives Demonstrate appropriate vaccine administration techniques Demonstrate appropriate vaccine administration.
Operational Casualty Care Course QuikClot Training LCDR Fermin S. Godinez Naval Medical Center Portsmouth Department of Emergency Medicine.
Contra Costa County CERT Program Unit 4A – Emergency Medical Operations Bandaging and Splinting Released: 10 January 2016.
GRAFT OF DIALYSIS The three most common types of access are:
Junctional Emergency Treatment Tool
Hemostasis after Trans Radial Intervention Division of Cardiology, Department of Internal Medicine Dongguk University Gyeongju Hospital Deuk-Young Nah,
CHITOSAN HEMOSTATIC BANDAGE. Chitosan Hemostatic Bandage Chitosan hemostatic bandages are an effective means to stop severe external hemorrhage. They.
Intravenous cannulation
HOME EMERGENCY GUIDE TAUFIQ ABDULLAH,MD EMERGENCY MEDICINE FACULTY OF MEDICINE, UNIVERSITY OF BRAWIJAYA EMERGENCY DEPARTMENT OF SAIFUL ANWAR HOSPITAL TAUFIQ.
Clinical Implications of D-Stat ® Dry in the Trauma Setting Gundu H. R. Rao*, Debra Cocking Johnson*, Steve Penegor**, Daniella Jentzsch** *Blood Biocompatibility.
Ten Tips for Dialysis Management
Sunil V. Rao MD The Duke Clinical Research Center
BIOSEAL ADVANCED Application
Patented Technology to Seal Arterial Access Sites
Junctional Emergency Treatment Tool
Carlos F. Bechara, MD, Suman Annambhotla, MD, Peter H. Lin, MD 
Contraceptive Implants Session V A: Two-Rod Implant Insertion
Contraceptive Implants Session V A: Two-Rod Implant Insertion
Presentation transcript:

Patented Technology Creating a Seal Over the Arterial Access Site

BIOSEAL ADVANCED Powder A topical hemostatic powder that controls external bleeding from vascular access procedures (primarily arterial) and percutaneous catheters. Powder ingredients are a hydrophilic polymer and potassium ferrate. The powder’s mechanism of action is a simultaneous two-step action whereby the hydrophilic polymer rapidly dehydrates the blood while the potassium ferrate binds with the blood proteins to create an occlusive seal.

Benefits of BIOSEAL ADVANCED Powder Quickly creates an occlusive seal that allows nothing in/nothing out of the vascular access site (seal is a microbial barrier) Reduces hold times, thus increasing patient comfort The seal stays with the patient Easy to use More cost-effective than vascular closure devices or hemostatic pads Nothing In Nothing Out

Powder + Pressure = Seal When placed on an access site and combined with manual pressure to the site, BIOSEAL ADVANCED Powder quickly forms an occlusive seal that covers the access site and stops blood flow. The natural clotting cascade builds an increasingly strong clot below the “BIOSEAL.” The “BIOSEAL” blocks the flow of blood OUT of the wound and helps prevent microbes from coming IN to the wound. BIOSEAL ADVANCED Powder forms a seal independently of the clotting cascade, meaning concomitant medications, including anticoagulants, need not be discontinued. The seal remains in place until wound healing is complete and it falls off naturally.

Target Applications Cath labs: Interventional Radiology: Sheath removal from arterial access procedures Interventional Radiology: Sheath removal from vascular access procedures Hemodialysis access maintenance (fistulas/grafts) Biopsies Other special diagnostic or interventional procedures

Proven Efficacy Through Clinical Study Fast hemostasis for diagnostic & interventional procedures In a trial comparing the efficacy of two compression adjuncts in 176 percutaneous vascular access procedures, BIOSEAL ADVANCED (PRO QR) was twice as fast as the control in achieving hemostasis for both venous and arterial procedures with no infections or adverse events. Procedure Type Time to Hemostasis BioSeal/Control Time Saved (min.) Arterial - Diagnostic 3.36/7.91 4.5 Arterial - Therapeutic 3.56/9.99 6.4 Arteriovenous Dialysis Access 3.41/7.26 3.8 Venous 1.93/3.96 2.0 *Wang DS, Chu LF, Olson SE, Miller FJ, Valji K, Wong WH, Rose SC, Austin M, Kuo MD. Comparative Evaluation of Noninvasive Compression Adjuncts for Hemostasis in Percutaneous Arterial, Venous, and Arteriovenous Dialysis Access Procedures. Journal of Vascular and Interventional Radiology January 2008; 19: 72-79. Effective in Controlling Severe Bleeding Results from a randomized 40-swine animal study of lethal arterial injury (6mm femoral arterial punch biopsy performed under a Dept. of Defense grant at the University of Michigan): BioSeal ADVANCED achieved significant results vs. controls.** Provided effective hemostasis in only 4 minutes 100% survival rate 77%+ decrease in hemorrhage volume Reduced resuscitation fluid needs **Controls included hemostatic agents for traumatic wounds.

Protocol for Femoral Sheath Removal Thoroughly clean and dry the area around the site. Withdraw sheath leaving at least 3 to 4 centimeters under the skin. Open package and remove PCD; remove paper backing and center PCD around sheath with slit towards the patient’s head. Pour powder into PCD to create a pile of powder around the sheath and completely fill the PCD. Lift sheath gently to ensure powder gets under sheath.  Place foam insert over the powder. Pull sheath slowly while applying pressure over the arteriotomy and the insertion site. BioSeal ADVANCED is an adjunct to manual pressure. For initial uses, start at current manual pressure times, then gradually adjust down towards 5 to 10 minutes of continuous pressure. Extend hold times as necessary based on anticoagulation levels (low platelets, high ACT levels), hypertensive patients or larger sheath sizes.

Protocol for Femoral Sheath Removal (cont’d) Release pressure slowly, rolling fingers off PCD. While stabilizing PCD center, gently clean PCD with gauze as needed. Dress securely with transparent dressing or tape. Place BioSeal ADVANCED product label on top of dressing to identify powder. Follow your normal ambulation protocol. Provide discharge instructions to patient or caregiver.

BioSeal ADVANCED for Fistula Declots and other AVDA Procedures BioSeal ADVANCED is efficacious for: • Challenging declots, fistulagrams, fistulaplasties and other access procedures • Patients with low platelet counts or anticoagulated patients (i.e. Heparin, Integrillin, Angiomax) “I routinely use BioSeal in access procedures. I tell people I call it “magic dust” ... and to try it, they will love it.” Scott O. Trerotola, MD Professor of Radiology and Surgery Associate Chair and Chief, Interventional Radiology University of Pennsylvania School of Medicine

BioSeal ADVANCED for Fistula Declots and other AVDA Procedures Let’s watch a procedure:

Protocol for Graft/Fistula Access Procedures Clean and dry area around site thoroughly. Withdraw sheath as much as possible leaving at least 2-3 cm under the skin. Open package and remove Powder Containment Device (PCD); remove paper backing and center PCD around sheath with slit towards head. Pour powder into PCD – lift sheath gently to ensure powder gets under sheath, then create a pile of powder around the sheath and completely fill the PCD. Place foam insert over the powder. Pull sheath slowly while holding pressure directly over the puncture site. (Ideally use one finger to ensure pressure is focused on puncture site).

Protocol for Graft/Fistula Access Procedures Hold continuous pressure for 5 minutes, focusing pressure over the access site to ensure initial seal forms. Increased hold times may be needed for: a) large sheaths (one minute of pressure per French size is a general guide.) b) hypertensive patients c) highly compromised blood. After 5 minutes, relieve pressure slightly without removing the foam center; then  assess site: If bleeding/oozing is visible through PCD, continue to apply additional pressure for 2 minutes and re-assess; if necessary, you can apply more BioSeal ADVANCED powder and resume holding. If no bleeding/oozing is visible, carefully clean PCD with clean gauze if necessary. Dress securely with transparent dressing or tape. Place BioSeal ADVANCED sticker on top of dressing to identify powder. Remind patient to minimize arm flexion for at least 30 minutes and to remove dressing as directed, leaving seal in place. Provide Patient Discharge Instructions to patient or caregiver. Avoid needle punctures through seal.

Tips for Success Remember “PAPC” Prep – patient assessment, including sheath size, blood pressure and level of anticoagulants (i.e., Heparin, Integrillin, Angiomax) Apply – completely apply powder under and around the sheath, creating a pile inside the PCD Pressure – hold consistent, normal pressure in the initial 5 minutes over the access site to allow seal formation. Cover – apply foam insert to assist with powder compression; secure with tape or transparent dressing.

BIOSEAL ADVANCED Ordering Information Order Number Product Description LP607 6 Applications per Box* LP637 24 Applications per Case* * Each application includes bottle, PCD, product description label and Patient Discharge Instructions.

In-Service/Support Tools Available Brochures for Patients and Medical Staff Protocol Sheets Posters

For More Information Contact Biolife at 800-722-7559 Visit www.biosealadvanced.com